KPX Lifescience.Co.Ltd (114450) — Cash Flow Reinvestment Rate
KPX Lifescience.Co.Ltd (114450) has a Cash Flow Reinvestment Rate of 0.23x as of September 2025, reinvesting ₩768.79 Million (capex ₩275.98 Million plus investments ₩492.81 Million) from operating cash flow of ₩3.33 Billion. See KPX Lifescience.Co.Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
KPX Lifescience.Co.Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for KPX Lifescience.Co.Ltd across 10 annual periods. For the full cash flow conversion analysis, see 114450 operating cash flow.
Annual Cash Flow Reinvestment Rate for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year capital reinvestment analysis for KPX Lifescience.Co.Ltd. See KPX Lifescience.Co.Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.12x | ₩3.74 Billion | ₩525.49 Million | ₩462.71 Million | ▼ -67.0% |
| 2023 | 21.60x | ₩7.99 Billion | ₩370.02 Million | ₩475.02 Million | ▲ +106.6% |
| 2021 | 10.45x | ₩6.39 Billion | ₩611.38 Million | ₩3.44 Billion | ▲ +152.0% |
| 2020 | 4.15x | ₩7.89 Billion | ₩1.90 Billion | ₩2.67 Billion | ▲ +74.1% |
| 2019 | 2.38x | ₩10.11 Billion | ₩4.24 Billion | ₩3.60 Billion | ▲ +46.5% |
| 2018 | 1.63x | ₩8.75 Billion | ₩5.38 Billion | ₩7.49 Billion | ▲ +78.2% |
| 2017 | 0.91x | ₩5.19 Billion | ₩5.68 Billion | ₩4.31 Billion | ▲ +39.7% |
| 2016 | 0.65x | ₩4.62 Billion | ₩7.07 Billion | ₩1.60 Billion | ▲ +123.3% |
| 2015 | 0.29x | ₩1.64 Billion | ₩5.62 Billion | ₩526.82 Million | ▼ -27.8% |
| 2014 | 0.41x | ₩1.65 Billion | ₩4.09 Billion | ₩838.78 Million | — |